GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Number of significant genes and fold change. by Gordon A. Barr (11163243)

“…Adult fear responses to a predator odor were decreased only by PN10-14 treatment and the infant Shock alone and Shock+mother did not differ.…”

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

Complication rates. by Hyun Soo Bae (15411910)

Subjects:

Postoperative pulmonary complications during a hospitalization. by Katelyn Morris (13943939)

Subjects:

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

“…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”

Data Sheet 1_Elevated relative humidity significantly decreases cannabinoid concentrations while delaying flowering development in Cannabis sativa L..docx by Ingrid Carolina Corredor-Perilla (22631510)

“…Furthermore, high RH significantly suppressed cannabinoid accumulation: cannabidiolic acid (CBD-A), cannabidiol (CBD), and cannabichromenic acid (CBC-A) levels decreased by approximately 4.9-fold, 3.2-fold, and 13-fold, respectively. …”

Surgical outcome and complication rates. by Timur Shamshudinov (12225685)

Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs by Chris Wallick (10131528)

Comparison of complication rates between groups. by Diego T. Dias (3151332)

Forest plot of complication rates. by Yuxian Chen (7551833)

“…At the final follow-up for ODI, the DF group demonstrated statistically superior outcomes compared to the DA group (MD = 1.28, 95%CI 0.35, 2.21, <i><i>P</i> </i>= 0.007). Data revealed no significant differences in SF12-PCS, JOA score, back pain VAS score, leg pain VAS score, final follow-up EQ-5D, reoperation rates, complication rates, and Odom’s criteria (<i><i>P</i> </i>> 0.05).…”

Trial sequential analysis (TSA) for complication rate. by Kuo-Chuan Hung (8587392)

Subjects:

<i>eIF2A</i> overexpression decreases the cell wall protein levels. by Laura Meyer (4033793)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …”

Log fold changes of genes involved in regulation of the complement pathway in the left ventricle [22] correspond to increased expression of pro-complement activation genes and decr... by Nicholas Markarian (18251668)

VOC Alpha spike protein shows decreased proteolytic processing. by Daniela Niemeyer (199082)

Aspartate and its metabolites are decreased in hypoxia. by Emily B. Cohen (9106088)

Analysis of wet/dry ratio and total weight gain during a 3 h EVLP run. by Henning Carstens (13132801)

Subjects:

Muscle-specific knockdown of <i>nSMase</i> decreases a subset of ceramide species that are decreased in <i>Gba1b</i> mutants. by Kathryn A. Jewett (3756811)